Related Experiment Video
Updated: Sep 13, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Regulation of the MDM2-p53 nexus by a nuclear phosphoinositide and small heat shock protein complex
Jeong Hyo Lee1, Mo Chen2, Tianmu Wen3
1University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Abstract:
The tumor suppressor p53 maintains genome stability in the setting of cellular stress and is frequently mutated in cancer. The stability of p53 is regulated by its interaction with the oncoprotein MDM2, a ubiquitin E3 ligase. Recently, nuclear phosphoinositides were reported to bind and stabilize p53. Here, we report that genotoxic stress induces the type I phosphatidylinositol phosphate kinase (PIPKIα) and its product phosphatidylinositol 4,5-bisphosphate (PIP2) to bind and regulate the stability and function of MDM2. Following genotoxic stress, nuclear PIPKIα binds to MDM2 to generate a complex of MDM2 and PIP2. PIP2 binding to MDM2 differentially regulates the recruitment of the small heat shock proteins (sHSPs) αB-crystallin (αBC) and HSP27 to the MDM2-PIP2 complex, acting as an on-off switch that regulates MDM2 stability, ubiquitination activity and interaction with p53. Our results demonstrate an unexpected role for nuclear phosphoinositides conferring specificity to the MDM2-PIP2-sHSPs association. Notably, the differential engagement of αBC and HSP27 reveals that sHSPs are not merely passive chaperones but play active, selective roles in fine-tuning MDM2 function and the MDM2-p53 nexus. These findings provide a previously unrecognized molecular framework for targeting this pathway in cancer.
Insights
Genotoxic stress activates PIPKIα, generating PIP2 that binds MDM2. This complex regulates MDM2 stability and its interaction with p53, revealing a new cancer therapy target.
Area of Science:
- Molecular Biology
- Cellular Stress Response
- Cancer Biology
Background:
- The tumor suppressor p53 is crucial for genome stability and frequently mutated in cancer.
- p53 stability is regulated by its interaction with the MDM2 oncoprotein, a ubiquitin E3 ligase.
- Nuclear phosphoinositides have recently been shown to bind and stabilize p53.
Purpose of the Study:
- To investigate the role of nuclear phosphoinositides in regulating MDM2 stability and function.
- To elucidate the mechanism by which genotoxic stress affects the MDM2-p53 interaction.
- To identify novel molecular targets for cancer therapy.
Main Methods:
- Investigated the interaction between genotoxic stress, PIPKIα, PIP2, MDM2, and p53.
- Utilized biochemical assays to analyze MDM2 stability, ubiquitination, and protein-protein interactions.
- Examined the differential recruitment of small heat shock proteins (sHSPs) to the MDM2-PIP2 complex.
Main Results:
- Genotoxic stress induces PIPKIα and PIP2, which bind to and regulate MDM2.
- PIP2 binding to MDM2 differentially controls the recruitment of αB-crystallin and HSP27.
- This differential recruitment acts as a switch, modulating MDM2 stability, ubiquitination, and p53 interaction.
Conclusions:
- Nuclear phosphoinositides confer specificity to the MDM2-PIP2-sHSPs association.
- sHSPs play active, selective roles in fine-tuning MDM2 function and the MDM2-p53 nexus.
- This pathway represents a novel molecular framework for cancer targeting.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response

